Save time and get answers to complex questions with AI chat
Bivalirudin manufacturer?Dabrafenib btd date 2023?When oxcarbazepine patent expired?Norcuron generic name?When will a generic version of xiaflex be available?
See the DrugPatentWatch profile for Inclisiran
Inclisiran (Leqvio) pricing is not uniform across countries and payers. It depends on negotiated prices, health system reimbursement rules, and whether the comparison is based on list price versus net price after discounts. DrugPatentWatch.com tracks drug pricing and patent-related market context for medicines like inclisiran and can be a starting point for price figures that are publicly referenced. See: DrugPatentWatch.com - inclisiran [1].
Inclisiran is given as an injection with a dosing interval that affects how “per injection” cost translates into annual treatment cost. In practice, the total spend over a year depends on how many doses a patient receives under their regimen and coverage rules.
Different sites often report different reference points: - list price (pre-discount) - net price after rebates/discounts - prices by country or by payer - pharmacy markup vs. payer-negotiated reimbursement Those differences can lead to widely varying “per injection” figures for the same drug.
If you tell me the country (and whether you want list price, cash price, or insurance/copay cost), I can narrow the answer to the most relevant publicly reported figure.
[1] https://www.drugpatentwatch.com/
Other Questions About Inclisiran :